Glenmede Trust’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Glenmede Trust’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-77	Closed	-$1K	–	2819
2015 Q4	$1K	Hold	77	–	–	﹤0.01%	2614
2015 Q3	$0	Sell	77 -261	-77%	-$6.66K	﹤0.01%	2934
2015 Q2	$9K	Buy	338 +77	+30%	+$2.24K	﹤0.01%	2133
2015 Q1	$7K	Buy	261 +160	+158%	+$4.41K	﹤0.01%	2201
2014 Q4	$2K	Buy	+101	New	+$2.96K	﹤0.01%	2438

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Glenmede Trust's MR Position: Q1 2016 in Review

Glenmede Trust sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 77 shares — an estimated $1K sold.

Glenmede Trust first reported a position in MR in Q4 2014 and held it in 5 quarters. The position peaked at $9K in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Glenmede Trust reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Glenmede Trust sold 77 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1K.
Glenmede Trust first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 5 quarters.
Glenmede Trust's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $9K in Q2 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Glenmede Trust's 13F filing for Q1 2016, filed 26 Apr 2016.